CD1D and neoplasm: ,45 The frequency of type 1 NKT and Vγ9Vδ2-T cells in patient tumor samples was within the range of those reported in healthy human donors and, importantly, Vγ9Vδ2-T cells exposed to CD1d-Vδ2 bsTCE in such samples could be readily activated.